Literature DB >> 22318382

The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ.

Li-Hua Lian1, Katelynn A Milora, Katherine K Manupipatpong, Liselotte E Jensen.   

Abstract

IL-36 is the common name for the three IL-1 family members IL-36α, IL-36β, and IL-36γ, formerly known as IL-1F6, IL-1F8, and IL-1F9, respectively. IL-36 appears to have pro-inflammatory activities; however, the physiological function of these cytokines remains unknown. Expression of IL-36 by keratinocytes implies its possible involvement in innate immune responses in the skin. We observed that, of the three IL-36 isoforms, human keratinocytes express high levels of IL-36γ. IL-36γ mRNA expression was dramatically induced by the Toll-like receptor ligands polyinosinic-polycytidylic acid (poly(I:C)) and flagellin. Surprisingly, the IL-36γ protein was released by cells treated with poly(I:C), but remained intracellular in cells treated with flagellin only. poly(I:C), but not flagellin, induced cell death and caspase-3/7 activation. Inhibition of caspase-3/7 and caspase-1 blocked extracellular release of IL-36γ from poly(I:C)-treated cells. Furthermore, caspase-1 inhibition prevented poly(I:C)-induced caspase-3/7 activation. Interestingly, transcription of the gene IL36G was dependent on caspase-1, but not caspase-3/7, activation. This demonstrates that the pathways leading to IL36G transcription and caspase-3/7 activation branch after caspase-1. This divergence of the pathways allows the cells to enter a state of de novo protein synthesis before committing to pyroptosis. Overall, our observations suggest that IL-36γ may be an alarmin that signals the cause, e.g., viral infection, of cell death.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318382      PMCID: PMC3326215          DOI: 10.1038/jid.2011.482

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

1.  Identification and initial characterization of four novel members of the interleukin-1 family.

Authors:  S Kumar; P C McDonnell; R Lehr; L Tierney; M N Tzimas; D E Griswold; E A Capper; R Tal-Singer; G I Wells; M L Doyle; P R Young
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 3.  Alarmins: chemotactic activators of immune responses.

Authors:  Joost J Oppenheim; De Yang
Journal:  Curr Opin Immunol       Date:  2005-08       Impact factor: 7.486

Review 4.  DAMPs, PAMPs and alarmins: all we need to know about danger.

Authors:  Marco E Bianchi
Journal:  J Leukoc Biol       Date:  2006-10-10       Impact factor: 4.962

5.  Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation.

Authors:  De Yang; Qian Chen; Helene F Rosenberg; Susanna M Rybak; Dianne L Newton; Zhao Yuan Wang; Qin Fu; Velizar T Tchernev; Minjuan Wang; Barry Schweitzer; Stephen F Kingsmore; Dhavalkumar D Patel; Joost J Oppenheim; O M Zack Howard
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

6.  Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs.

Authors:  Jennifer E Towne; Kirsten E Garka; Blair R Renshaw; G Duke Virca; John E Sims
Journal:  J Biol Chem       Date:  2004-01-20       Impact factor: 5.157

7.  Caspases 3 and 7: key mediators of mitochondrial events of apoptosis.

Authors:  Saquib A Lakhani; Ali Masud; Keisuke Kuida; George A Porter; Carmen J Booth; Wajahat Z Mehal; Irteza Inayat; Richard A Flavell
Journal:  Science       Date:  2006-02-10       Impact factor: 47.728

8.  The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes.

Authors:  Laurence Feldmeyer; Martin Keller; Gisela Niklaus; Daniel Hohl; Sabine Werner; Hans-Dietmar Beer
Journal:  Curr Biol       Date:  2007-07-03       Impact factor: 10.834

9.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

10.  Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation.

Authors:  Hal Blumberg; Huyen Dinh; Esther S Trueblood; James Pretorius; David Kugler; Ning Weng; Suzanne T Kanaly; Jennifer E Towne; Cynthia R Willis; Melanie K Kuechle; John E Sims; Jacques J Peschon
Journal:  J Exp Med       Date:  2007-10-01       Impact factor: 14.307

View more
  46 in total

1.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

2.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

3.  IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.

Authors:  Angelo Massimiliano D'Erme; Dagmar Wilsmann-Theis; Julia Wagenpfeil; Michael Hölzel; Sandra Ferring-Schmitt; Sonja Sternberg; Miriam Wittmann; Bettina Peters; Andreas Bosio; Thomas Bieber; Joerg Wenzel
Journal:  J Invest Dermatol       Date:  2014-12-19       Impact factor: 8.551

4.  IL-36γ is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components.

Authors:  Melissa A Kovach; Benjamin H Singer; Michael W Newstead; Xianying Zeng; Thomas A Moore; Eric S White; Steven L Kunkel; Marc Peters-Golden; Theodore J Standiford
Journal:  J Leukoc Biol       Date:  2016-02-10       Impact factor: 4.962

5.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

6.  IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.

Authors:  Xuefeng Wang; Xin Zhao; Chao Feng; Aliyah Weinstein; Rui Xia; Wen Wen; Quansheng Lv; Shuting Zuo; Peijun Tang; Xi Yang; Xiaojuan Chen; Hongrui Wang; Shayang Zang; Lindsay Stollings; Timothy L Denning; Jingting Jiang; Jie Fan; Guangbo Zhang; Xueguang Zhang; Yibei Zhu; Walter Storkus; Binfeng Lu
Journal:  Cancer Cell       Date:  2015-08-27       Impact factor: 31.743

Review 7.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

8.  Homology modeling and structural comparison of leucine rich repeats of Toll like receptors 1-10 of ruminants.

Authors:  Anandan Swathi; Gopal Dhinakar Raj; Angamuthu Raja; Krishnaswamy Gopalan Tirumurugaan
Journal:  J Mol Model       Date:  2013-06-28       Impact factor: 1.810

9.  Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.

Authors:  M-A Boutet; G Bart; M Penhoat; J Amiaud; B Brulin; C Charrier; F Morel; J-C Lecron; M Rolli-Derkinderen; A Bourreille; S Vigne; C Gabay; G Palmer; B Le Goff; F Blanchard
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

Review 10.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.